Investment column: MDIS
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.AFTER EIGHT profits warnings, it's no surprise MDIS's results still defeated expectations. The software installer's last warning, in July, was insufficient. Collins Stewart, the housebroker, has now downgraded full year forecasts from a pounds 2.5m loss to a whopping pounds 10m loss. Is there no end to MDIS shareholders' misery?
The shares' 16 per cent fall doesn't entirely reflect a fourfold increase in expected losses, suggesting the shares have bottomed. A new chief executive, Chris Stone, took the helm yesterday after John Klein abruptly departed. Mr Stone says MDIS's problems in the US, where it acquired companies it couldn't control, led to management taking its eye off the ball in UK. Fixing the problem is a matter of better management and focusing on fewer products, he says.
Interim results show the extent of the problem. UK sales rose 8 per cent but profits fell 17 per cent. In the US, the Glovia and Pro IV ERP businesses also widened both sales and losses. MDIS hopes to secure a deal with Fujitsu, its partner in the US operations, to scale down its stake.
Taking MDIS back to its pounds 260m flotation value will take time. Mr Stone sees it breaking even at the operating level in 2000, though exceptional restructuring charges could keep it in the red.
Still, MDIS has retained a decent customer base in a market growing at 20 per cent annually. The shares, at 19.25p, are now worth a punt.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments